Analysts expect iSpecimen Inc. to report revenue of 3.14 M for Q4 24, against a range of 3.02 M to 3.27 M. The most recent reported quarter, Q1 26, came in at 156,009.00, a 97.8% miss against the 7.02 M consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.29 M | 2.86 M | 2.66 M | - | 1.06 M | 713,135.00 | 106,592.00 | 51,761.00 | 156,009.00 | - | - | - | - | - | - | - |
| High Estimate | 2.95 M | 3.32 M | 3.20 M | 3.27 M | 2.61 M | 3.18 M | 3.79 M | 3.34 M | 7.35 M | 10.76 M | 11.30 M | 12.61 M | 8.21 M | 9.98 M | 12.08 M | 13.18 M |
| Low Estimate | 2.50 M | 2.73 M | 2.86 M | 3.02 M | 2.26 M | 2.76 M | 3.11 M | 3.13 M | 6.68 M | 9.06 M | 9.25 M | 10.89 M | 7.59 M | 9.16 M | 10.39 M | 11.34 M |
| Consensus Estimate | 2.73 M | 3.02 M | 3.03 M | 3.14 M | 2.44 M | 2.97 M | 3.45 M | 3.23 M | 7.02 M | 9.91 M | 10.28 M | 11.75 M | 7.90 M | 9.57 M | 11.24 M | 12.26 M |
Analysts expect iSpecimen Inc. to report earnings per share of -167.32 for Q4 24, against a range of -176.89 to -157.75. The most recent reported quarter, Q1 26, came in at -7.77, a 94.1% beat against the -132.80 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -256.00 | -152.00 | -84.00 | - | -31.22 | -34.69 | -19.38 | -29.33 | -7.77 | - | - | - |
| High Estimate | -198.84 | -197.32 | -137.57 | -157.75 | -179.19 | -139.46 | -138.27 | -139.00 | -125.18 | -114.55 | -147.76 | -155.02 |
| Low Estimate | -223.56 | -240.04 | -156.51 | -176.89 | -193.89 | -149.38 | -152.97 | -151.18 | -140.42 | -131.71 | -171.36 | -167.12 |
| Consensus Estimate | -211.20 | -218.68 | -147.04 | -167.32 | -186.54 | -144.42 | -145.62 | -145.09 | -132.80 | -123.13 | -159.56 | -161.07 |